company background image
INNOVACAP logo

Innova Captab NSEI:INNOVACAP Stock Report

Last Price

₹869.00

Market Cap

₹49.7b

7D

-6.2%

1Y

75.1%

Updated

22 May, 2025

Data

Company Financials +

Innova Captab Limited

NSEI:INNOVACAP Stock Report

Market Cap: ₹49.7b

INNOVACAP Stock Overview

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. More details

INNOVACAP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth6/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Rewards

Price-To-Earnings ratio (38.8x) is below the Life Sciences industry average (49.2x)

Earnings are forecast to grow 28.34% per year

Earnings have grown 25.4% per year over the past 5 years

Risk Analysis

High level of non-cash earnings


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Innova Captab Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Innova Captab
Historical stock prices
Current Share Price₹869.00
52 Week High₹1,260.00
52 Week Low₹421.35
Beta0
1 Month Change-3.94%
3 Month Change10.82%
1 Year Change75.11%
3 Year Changen/a
5 Year Changen/a
Change since IPO60.51%

Recent News & Updates

Innova Captab Limited (NSE:INNOVACAP) Just Released Its Full-Year Earnings: Here's What Analysts Think

May 23
Innova Captab Limited (NSE:INNOVACAP) Just Released Its Full-Year Earnings: Here's What Analysts Think

Innova Captab Limited's (NSE:INNOVACAP) Intrinsic Value Is Potentially 26% Below Its Share Price

Mar 12
Innova Captab Limited's (NSE:INNOVACAP) Intrinsic Value Is Potentially 26% Below Its Share Price

Recent updates

Innova Captab Limited (NSE:INNOVACAP) Just Released Its Full-Year Earnings: Here's What Analysts Think

May 23
Innova Captab Limited (NSE:INNOVACAP) Just Released Its Full-Year Earnings: Here's What Analysts Think

Innova Captab Limited's (NSE:INNOVACAP) Intrinsic Value Is Potentially 26% Below Its Share Price

Mar 12
Innova Captab Limited's (NSE:INNOVACAP) Intrinsic Value Is Potentially 26% Below Its Share Price

Innova Captab Limited's (NSE:INNOVACAP) 25% Share Price Plunge Could Signal Some Risk

Feb 19
Innova Captab Limited's (NSE:INNOVACAP) 25% Share Price Plunge Could Signal Some Risk

Here's Why Innova Captab (NSE:INNOVACAP) Can Manage Its Debt Responsibly

Jan 29
Here's Why Innova Captab (NSE:INNOVACAP) Can Manage Its Debt Responsibly

Even With A 27% Surge, Cautious Investors Are Not Rewarding Innova Captab Limited's (NSE:INNOVACAP) Performance Completely

Aug 01
Even With A 27% Surge, Cautious Investors Are Not Rewarding Innova Captab Limited's (NSE:INNOVACAP) Performance Completely

Innova Captab (NSE:INNOVACAP) Has A Pretty Healthy Balance Sheet

Jul 19
Innova Captab (NSE:INNOVACAP) Has A Pretty Healthy Balance Sheet

We Think That There Are Issues Underlying Innova Captab's (NSE:INNOVACAP) Earnings

Jun 06
We Think That There Are Issues Underlying Innova Captab's (NSE:INNOVACAP) Earnings

What Innova Captab Limited's (NSE:INNOVACAP) P/E Is Not Telling You

May 21
What Innova Captab Limited's (NSE:INNOVACAP) P/E Is Not Telling You

Shareholder Returns

INNOVACAPIN Life SciencesIN Market
7D-6.2%3.4%-0.3%
1Y75.1%43.7%1.3%

Return vs Industry: INNOVACAP exceeded the Indian Life Sciences industry which returned 44.8% over the past year.

Return vs Market: INNOVACAP exceeded the Indian Market which returned 2.7% over the past year.

Price Volatility

Is INNOVACAP's price volatile compared to industry and market?
INNOVACAP volatility
INNOVACAP Average Weekly Movement6.7%
Life Sciences Industry Average Movement7.4%
Market Average Movement7.0%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.7%

Stable Share Price: INNOVACAP has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: INNOVACAP's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aVinay Lohariwalainnovacaptab.com

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals.

Innova Captab Limited Fundamentals Summary

How do Innova Captab's earnings and revenue compare to its market cap?
INNOVACAP fundamental statistics
Market cap₹49.73b
Earnings (TTM)₹1.28b
Revenue (TTM)₹12.56b
38.8x
P/E Ratio
4.0x
P/S Ratio

Is INNOVACAP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INNOVACAP income statement (TTM)
Revenue₹12.56b
Cost of Revenue₹8.14b
Gross Profit₹4.42b
Other Expenses₹3.13b
Earnings₹1.28b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)22.41
Gross Margin35.17%
Net Profit Margin10.21%
Debt/Equity Ratio35.0%

How did INNOVACAP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 01:40
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Innova Captab Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Abdulkader PuranwalaICICI Securities Ltd.
Amey ChalkeJM Financial Institutional Securities Limited